Dr Paul Joyce

Dr Paul Joyce 
Head of the Translational Nanomedicine and Biotherapeutics Group, University of South Australia 

Dr Paul Joyce’s research focuses on harnessing drug delivery approaches for transforming therapeutic outcomes across cancer, mental health, and antimicrobial resistance.  

Working at the interface of materials science and drug development, Dr Joyce engages closely with stakeholders who enable clinical and commercial translation of his research, including the pharmaceutical industry, clinicians and health consumers. Dr Joyce’s leadership within this field is evidenced through his publication of more than 70 peer-reviewed papers in leading international journals, three book chapters, and three granted international patents for novel nanomedicine inventions. 

Further, Dr Joyce is a Director of the Australian Controlled Release Society, the leading society for delivery science, and has been awarded more than $9 million in funding to undertake his research, including serving as a current Hospital Research Foundation Fellow and Cancer Council SA Fellow.